What does InterCure Ltd. do?

InterCure Ltd. (INCR.TA) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is INCR.TA's market cap?

InterCure Ltd. (INCR.TA) has a market capitalization of approximately $20.61 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does INCR.TA pay a dividend?

No — InterCure Ltd. (INCR.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is INCR.TA profitable?

InterCure Ltd. (INCR.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

INCR.TA

InterCure Ltd.

TLV·Drug Manufacturers, Specialty & Generic · Healthcare

ILA 1,740.00ILA 20.00+1.16%

Market capILA 20.61B·Aug 26 1:05 PM UTC

Price Chart

ILA 1,740.00+ILA 20.00 (+1.16%)today

−82.57%CAGR −29.49%

Select date range

FromTo

Sep 10, 2007Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

INCR.TA does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateApr 29

Last Report DateSep 1

Reported vs Estimate−ILA 1.70

Earnings Surprise—

FinancialsFinancials Tab

Revenue₪270.20M

Net Income−₪35.71M

Net Margin−13.2%

Operating Cash Flow₪16.84M

Capital Expenditures₪3.55M

Free Cash Flow₪13.29M

Return on Equity−9.0%

Return on Invested Capital−2.8%

Net Debt₪136.34M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for INCR.TA and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how INCR.TA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for INCR.TA and 80,000+ other tickers.

About InterCure Ltd.

InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to production, marketing, and distribution of medical cannabis products. The company's product line features dried cannabis flowers and an oil-based cannabis extract. Additionally, InterCure allocates investments to the biomedical sector. Established in 1994, the firm's main headquarters are situated in Herzliya, Israel.

CEO: Alexander Rabinovich
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: TLV
Employees: 285
Website: www.intercure.co

Peers

Oramed Pharmaceuticals Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About INCR.TA

What does InterCure Ltd. do?: InterCure Ltd. (INCR.TA) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is INCR.TA's market cap?: InterCure Ltd. (INCR.TA) has a market capitalization of approximately $20.61 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does INCR.TA pay a dividend?: No — InterCure Ltd. (INCR.TA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is INCR.TA profitable?: InterCure Ltd. (INCR.TA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.